How I treat pediatric acute myeloid leukemia.

Blood
Jeffrey E Rubnitz

Abstract

Acute myeloid leukemia is a heterogeneous disease that accounts for approximately 20% of acute leukemias in children and adolescents. Despite the lack of targeted therapy for most subtypes and a dearth of new agents, survival rates have reached approximately 60% for children treated on clinical trials in developed countries. Most of the advances have been accomplished by better risk classification, the implementation of excellent supportive care measures, adaptation of therapy on the basis of each patient's response to therapy, and improvements in allogeneic hematopoietic stem cell transplantation. However, it is unlikely that further gains can be made through these measures alone. In this regard, high-resolution, genome-wide analyses have led to greater understanding of the pathogenesis of this disease and the identification of molecular abnormalities that are potential targets of new therapies. The development of molecularly targeted agents, some of which are already in clinical trials, holds great promise for the future.

References

Oct 16, 1996·Journal of the National Cancer Institute·E L SieversM R Loken
Apr 17, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maria E Suarez-AlmazorEduardo Bruera
May 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey E RubnitzFrederick G Behm
Jul 26, 2002·British Journal of Haematology·Alan K BurnettUNKNOWN Medical Research Council Adult and Paediatric Working Parties
Sep 13, 2003·Leukemia·M Levis, D Small
Oct 9, 2003·British Journal of Haematology·Elaine Coustan-SmithDario Campana
Jun 23, 2006·Blood·Soheil MeshinchiTodd A Alonzo
Jul 21, 2006·Pediatric Blood & Cancer·Dorothy R BarnardUNKNOWN Children's Oncology Group
Aug 17, 2006·Blood·Soheil MeshinchiJerald P Radich
Sep 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ursula CreutzigDirk Reinhardt
Sep 23, 2006·The New England Journal of Medicine·Craig T JordanMark Noble
Feb 16, 2008·British Journal of Haematology·Asahito HamaSeiji Kojima
Oct 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John T HoranUNKNOWN Children's Oncology Group
Nov 7, 2008·Nature·Timothy J LeyRichard K Wilson
Jun 25, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Soheil Meshinchi, Frederick R Appelbaum
Jun 26, 2009·The New England Journal of Medicine·Ching-Hon PuiMary V Relling
Jul 22, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ichiro TsukimotoRyoji Hanada
Aug 5, 2009·Proceedings of the National Academy of Sciences of the United States of America·Ina RadtkeJames R Downing
Aug 7, 2009·The New England Journal of Medicine·Elaine R MardisTimothy J Ley
Sep 25, 2009·The New England Journal of Medicine·Bob LöwenbergUNKNOWN Swiss Group for Clinical Cancer Research (SAKK) Collaborative Group
Sep 25, 2009·The New England Journal of Medicine·Hugo F FernandezMartin S Tallman
Sep 26, 2009·Clinical Lymphoma & Myeloma·David ShookDario Campana

❮ Previous
Next ❯

Citations

Jun 12, 2013·Journal of Cancer Survivorship : Research and Practice·Stephanie M PerkinsHaydar Frangoul
Oct 26, 2013·Paediatric Drugs·Jennifer DavilaThomas Renaud
May 20, 2014·British Journal of Haematology·Gertjan Kaspers
Jun 11, 2016·Current Problems in Pediatric and Adolescent Health Care·P Pallavi MadhusoodhanTeena Bhatla
Jan 19, 2016·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·B GonzálezA Pérez-Martínez
Jun 26, 2014·British Journal of Haematology·Costa BachasGertjan J L Kaspers
Jul 6, 2017·International Journal of Molecular Sciences·Yordan SbirkovKevin Petrie
Feb 22, 2018·Biomedicines·Sarah K TasianSergio Rutella
Jul 12, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Solida LongMadalena M M Pinto
Dec 1, 2017·International Journal of Molecular Sciences·Geoffrey Brown, Ewa Marcinkowska
Dec 7, 2017·Frontiers in Pediatrics·Amy N Sexauer, Sarah K Tasian
Aug 18, 2018·Journal of Cellular and Molecular Medicine·Olga PereiraPaula Ludovico
Aug 1, 2019·Stem Cells and Development·Lacey Brennan, Aru Narendran
Sep 19, 2014·Expert Review of Hematology·J Timothy CaldwellJeffrey W Taub
Jan 9, 2020·Expert Opinion on Pharmacotherapy·Nira Arad-CohenYael Shachor-Meyouhas
Jan 29, 2020·Expert Review of Hematology·Tianyou YanYuping Gong
Jul 29, 2020·Blood Research·Hyery Kim
Oct 29, 2014·Expert Review of Hematology·Nicolas DuployezClaude Preudhomme
Aug 31, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Z CaiH Wu
Apr 17, 2019·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·B HousouA Quessar
Apr 13, 2021·Pediatric Blood & Cancer·Grace EganJohann Hitzler
Jul 27, 2021·Journal of Oncology·Wei YanJian Zhang
Aug 23, 2021·Paediatric Drugs·LaQuita M JonesTodd Cooper

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.